These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 9351392)
1. Topographical association between the cyclin-dependent kinases inhibitor P21, p53 accumulation, and cellular proliferation in human atherosclerotic tissue. Ihling C; Menzel G; Wellens E; Mönting JS; Schaefer HE; Zeiher AM Arterioscler Thromb Vasc Biol; 1997 Oct; 17(10):2218-24. PubMed ID: 9351392 [TBL] [Abstract][Full Text] [Related]
2. Co-expression of p53 and MDM2 in human atherosclerosis: implications for the regulation of cellularity of atherosclerotic lesions. Ihling C; Haendeler J; Menzel G; Hess RD; Fraedrich G; Schaefer HE; Zeiher AM J Pathol; 1998 Jul; 185(3):303-12. PubMed ID: 9771485 [TBL] [Abstract][Full Text] [Related]
3. Concordant upregulation of type II-TGF-beta-receptor, the cyclin-dependent kinases inhibitor P27Kip1 and cyclin E in human atherosclerotic tissue: implications for lesion cellularity. Ihling C; Technau K; Gross V; Schulte-Mönting J; Zeiher AM; Schaefer HE Atherosclerosis; 1999 May; 144(1):7-14. PubMed ID: 10381272 [TBL] [Abstract][Full Text] [Related]
4. Expression patterns of cyclins D1, E and cyclin-dependent kinase inhibitors p21(Waf1/Cip1) and p27(Kip1) in urothelial carcinoma: correlation with other cell-cycle-related proteins (Rb, p53, Ki-67 and PCNA) and clinicopathological features. Ioachim E; Michael M; Stavropoulos NE; Kitsiou E; Hastazeris K; Salmas M; Stefanaki S; Agnantis NJ Urol Int; 2004; 73(1):65-73. PubMed ID: 15263796 [TBL] [Abstract][Full Text] [Related]
5. Association between polymorphism in p21(Waf1/Cip1) cyclin-dependent kinase inhibitor gene and human oral cancer. Ralhan R; Agarwal S; Mathur M; Wasylyk B; Srivastava A Clin Cancer Res; 2000 Jun; 6(6):2440-7. PubMed ID: 10873097 [TBL] [Abstract][Full Text] [Related]
6. Expression of p21(WAF1/CIP1) and p53 proteins in gastric carcinoma: its relationships with cell proliferation activity and prognosis. Liu XP; Tsushimi K; Tsushimi M; Kawauchi S; Oga A; Furuya T; Sasaki K Cancer Lett; 2001 Sep; 170(2):183-9. PubMed ID: 11463497 [TBL] [Abstract][Full Text] [Related]
7. Expression of cyclins A and D and p21(waf1/cip1) proteins in renal cell cancer and their relation to clinicopathological variables and patient survival. Aaltomaa S; Lipponen P; Ala-Opas M; Eskelinen M; Syrjänen K; Kosma VM Br J Cancer; 1999 Aug; 80(12):2001-7. PubMed ID: 10471053 [TBL] [Abstract][Full Text] [Related]
8. p21WAF1 immunohistochemical expression in breast carcinoma: correlations with clinicopathological data, oestrogen receptor status, MIB1 expression, p53 gene and protein alterations and relapse-free survival. Barbareschi M; Caffo O; Doglioni C; Fina P; Marchetti A; Buttitta F; Leek R; Morelli L; Leonardi E; Bevilacqua G; Dalla Palma P; Harris AL Br J Cancer; 1996 Jul; 74(2):208-15. PubMed ID: 8688323 [TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical detection of p53, mdm2, waf1/p21, and Ki67 proteins in bone marrow biopsies in myelodysplastic syndroms, acute myelogenous leukaemias and chronic myeloproliferative disorders. Kanavaros P; Stefanaki K; Rontogianni D; Darivianaki K; Vlychou M; Papadaki E; Eliopoulos G; Bakiri M; Matsouka C; Kakolyris S; Georgoulias V Clin Exp Pathol; 1999; 47(5):231-8. PubMed ID: 10598372 [TBL] [Abstract][Full Text] [Related]
10. Tranilast inhibits vascular smooth muscle cell growth and intimal hyperplasia by induction of p21(waf1/cip1/sdi1) and p53. Takahashi A; Taniguchi T; Ishikawa Y; Yokoyama M Circ Res; 1999 Mar; 84(5):543-50. PubMed ID: 10082476 [TBL] [Abstract][Full Text] [Related]
11. Analysis of p53, p21(Waf1/Cip1) and TGF-beta(3) immunohistochemical staining in Bowen's disease. Kawakami T; Soma Y; Mizoguchi M; Saito R Dermatology; 2001; 202(1):9-15. PubMed ID: 11244221 [TBL] [Abstract][Full Text] [Related]
12. Patterns of p21(waf1/cip1) expression in non-papillomatous nasal mucosa, endophytic sinonasal papillomas, and associated carcinomas. Schwerer MJ; Sailer A; Kraft K; Baczako K; Maier H J Clin Pathol; 2001 Nov; 54(11):871-6. PubMed ID: 11684723 [TBL] [Abstract][Full Text] [Related]
13. Subcellular localisation of cyclin B, Cdc2 and p21(WAF1/CIP1) in breast cancer. association with prognosis. Winters ZE; Hunt NC; Bradburn MJ; Royds JA; Turley H; Harris AL; Norbury CJ Eur J Cancer; 2001 Dec; 37(18):2405-12. PubMed ID: 11720835 [TBL] [Abstract][Full Text] [Related]
14. Expression and alteration of p53 and p21(waf1/cip1) influence the sensitivity of chemoradiation therapy for esophageal cancer. Shimoyama S; Konishi T; Kawahara M; Aoki F; Harada N; Shimizu S; Murakami T; Kaminishi M Hepatogastroenterology; 1998; 45(23):1497-504. PubMed ID: 9840093 [TBL] [Abstract][Full Text] [Related]
15. Expression of p21(waf1/cip1) protein in transitional cell bladder tumours and its prognostic value. Lipponen P; Aaltomaa S; Eskelinen M; Ala-Opas M; Kosma VM Eur Urol; 1998 Sep; 34(3):237-43. PubMed ID: 9732201 [TBL] [Abstract][Full Text] [Related]
16. [Expression of P21 WAF1/CIP1 in human astrocytomas in correlating with P53, MDM2, and cellular proliferation index]. Xu QZ; Liu F; Lu DH; Yu SZ; Yang H Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2001 Aug; 23(4):341-5. PubMed ID: 12940073 [TBL] [Abstract][Full Text] [Related]